HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Nicotine dependence — Clinical Guidelines

Overview

Nicotine dependence is characterized by compulsive use of nicotine-containing products despite harmful consequences, driven by neuroadaptations that enhance addiction 9. It significantly impacts public health, with diverse methods of nicotine delivery, including traditional cigarettes and newer e-cigarettes, posing varying risks 1 2 3.

Diagnosis

Key Criteria: Compulsive use, difficulty quitting, tolerance, withdrawal symptoms, and continued use despite adverse consequences 12.

Recommended Tests: No specific laboratory tests; diagnosis primarily clinical based on history and Fagerstrom Tolerance Questionnaire 12.

Grading: Severity can be assessed using validated scales like the Fagerstrom Nicotine Dependence Scale 12.

Management

First-Line Treatments:

- Nicotine Replacement Therapy (NRT): Patches, gum, lozenges, inhalers, and nasal sprays 9. - Bupropion (Sustained-Release): Enhances abstinence rates when combined with NRT 7.

Adjunctive Treatments:

- Behavioral Counseling: Essential component alongside pharmacotherapy 7. - Combination Therapy: Combining NRT with bupropion or counseling shows improved outcomes 7.

Special Populations

Pregnancy: Clinicians often report low awareness of effective treatments; counseling and NRT are generally considered safe but require careful consideration 8.

Pediatrics: High risk of liquid nicotine toxicity due to concentrated e-liquids; immediate medical attention required for exposure 2 4.

Elderly: Specific guidelines are less detailed; tailored approaches focusing on safety and efficacy are recommended 9.

Key Recommendations

Utilize Combination Therapies: Combining nicotine replacement therapy with bupropion or behavioral counseling significantly enhances cessation rates (Evidence: Strong 7).

Enhance Clinician Education: Increase awareness and knowledge among healthcare providers regarding effective treatments for nicotine dependence during pregnancy and postpartum (Evidence: Moderate 8).

Monitor Pediatric Exposure: Implement stringent safety measures and public education to prevent pediatric exposure to concentrated liquid nicotine (Evidence: Strong 2 4).

Consider Ethnic Variations: Tailor cessation interventions considering potential differences in response among racial/ethnic groups (Evidence: Moderate 5).

Educate on E-Cigarette Risks: Inform the public and practitioners about the health risks associated with e-cigarettes, particularly among youth (Evidence: Moderate 1).

References

1 Kouzoukas E, Navas C, Zawertailo L, Fougere C, Bacon SL, Chadi N et al.. The health effects of vaping and e-cigarettes: consensus recommendations. The International journal on drug policy 2026. link 2 Howard MB, Guse S. Liquid Nicotine, E-Cigarettes, and Vaping: Information for the Pediatric Emergency Medicine Provider. Pediatric emergency care 2022. link 3 Scarpino M, Rosso T, Lanzo G, Lolli F, Bonizzoli M, Lazzeri C et al.. Severe neurological nicotine intoxication by e-cigarette liquids: Systematic literature review. Acta neurologica Scandinavica 2021. link 4 Akhavan AR, Burns R, Stone K, Reid J, Mazor S. Pediatric Toxidrome Simulation Curriculum: Liquid Nicotine Overdose. MedEdPORTAL : the journal of teaching and learning resources 2018. link 5 Covey LS, Botello-Harbaum M, Glassman AH, Masmela J, LoDuca C, Salzman V et al.. Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity. Ethnicity & disease 2008. link 6 Lee B, Yang CH, Hahm DH, Lee HJ, Choe ES, Pyun KH et al.. Coptidis Rhizoma attenuates repeated nicotine-induced behavioural sensitization in the rat. The Journal of pharmacy and pharmacology 2007. link 7 Ingersoll KS, Cohen J. Combination treatment for nicotine dependence: state of the science. Substance use & misuse 2005. link 8 Bonollo DP, Zapka JG, Stoddard AM, Ma Y, Pbert L, Ockene JK. Treating nicotine dependence during pregnancy and postpartum: understanding clinician knowledge and performance. Patient education and counseling 2002. link00023-x) 9 Balfour D, Benowitz N, Fagerström K, Kunze M, Keil U. Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report. European heart journal 2000. link 10 Richman PB, Dinowitz S, Nashed A, Eskin B, Cody R. Prevalence of smokers and nicotine-addicted patients in a suburban emergency department. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 1999. link 11 Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K et al.. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug metabolism and disposition: the biological fate of chemicals 1996. link 12 Moore BL, Schneider JA, Ryan JJ. Fagerstrom's Tolerance Questionnaire: clarification of item and scoring ambiguities. Addictive behaviors 1987. link90010-4)

Nicotine dependence